Plus Therapeutics gets Nasdaq delisting notice for negative stockholders' equity

PLUS THERAPEUTICS, INC.

Company reported stockholders' equity deficit of $23.6M as of March 31, 2025, failing Nasdaq's $2.5M minimum.
Nasdaq staff determined to delist securities; company must request a hearing by June 10, 2025.
Common stock (PSTV) continues trading on Nasdaq Capital Market pending hearing decision.
Company plans to appeal; hearing typically scheduled 30-45 days after request.
Previously regained compliance on equity requirement on March 7, 2025, but fell back into non-compliance.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.